Following the onset of the COVID-19 pandemic, people with scleroderma experienced substantial increases in anxiety, but not depression, a…
Articles by Marisa Wexler, MS
A protein known as TL1A drives lung fibrosis, or scarring, in scleroderma, a new study suggests. The findings suggest…
Detailed characteristics of 12 cases of lung cancer in people with scleroderma were described in a new study.
Obstructive sleep apnea (OSA) is associated with an increased risk of pulmonary hypertension in people with scleroderma, a study suggests.
The U.S. Food and Drug Administration has granted orphan drug designation to Theraly Fibrosis’ TLY012 for the treatment…
With the World Scleroderma Foundation (WSF)’s support, experts worldwide answered questions in the form of  recommendations for scleroderma…
Heart and kidney imaging may help detect fibrosis, or scarring, in asymptomatic people with scleroderma, and could be useful in…
One year of treatment with Tracleer (bosentan) significantly reduces the severity of patient-reported skin symptoms in people with…
The types of autoantibodies a person has are a better predictor of scleroderma prognosis than whether the person has other…
Scleroderma patients who develop digital ulcers are more likely to be younger at disease onset, male, and have…